Applied PK Lecture: Tsu (July 3rd)

studied byStudied by 12 people
5.0(1)
Get a hint
Hint

What is the reversal agent for Digoxin?

1 / 31

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

32 Terms

1

What is the reversal agent for Digoxin?

Digoxin-specific antibody Fab fragments (DigiFab).

New cards
2

Why does DigiFab work effectively as a reversal agent for Digoxin?

It has a higher affinity to digoxin than the Na+/K+ ATPase digoxin receptor site and irreversibly binds to digoxin.

New cards
3

Can Digoxin levels be accurately measured immediately after DigiFab administration?

No because the levels are falsely elevated.

New cards
4

What should be monitored after administering DigiFab?

Monitor for resolution of arrhythmias and gastrointestinal (GI) adverse effects.

New cards
5

How is DigiFab administered?

DigiFab is administered intravenously (IV).

New cards
6

What is the onset of action for DigiFab?

The onset of action for DigiFab is approximately 20 minutes.

New cards
7

What is the average time to maximal response after administering DigiFab?

The average time to maximal response is about 90 minutes.

New cards
8

How is the dose of DigiFab determined when the digoxin dose and timing of toxicity are known?

For an acute known dose, the dose is calculated as digoxin load in mg / 0.5 mg digoxin bound per vial.

New cards
9

How many vials of DigiFab are administered for an acute unknown dose of digoxin?

For an acute unknown dose, 10-20 vials are administered, and the patient is monitored closely.

New cards
10

How many vials of DigiFab are administered for a chronic unknown dose of digoxin?

For a chronic unknown dose, 6 vials are administered, and the patient is monitored closely.

New cards
11

How is the DigiFab dose determined for a chronic known dose of digoxin?

The dose is calculated as (digoxin steady-state level x weight) / 100.

New cards
12

What is the primary indication for Lidocaine in this lecture?

Treatment of ventricular arrhythmias.

New cards
13

What class of antiarrhythmic is Lidocaine?

Class IB antiarrhythmic.

New cards
14

How is Lidocaine administered for the treatment of ventricular arrhythmias?

It is administered intravenously (IV) only.

New cards
15

What is the usual bolus dosing of Lidocaine for ventricular arrhythmias?

The usual bolus dose is 1 to 1.5 mg/kg.

New cards
16

What is the usual continuous infusion rate of Lidocaine after the bolus dose?

The continuous infusion rate is 1 to 4 mg/min.

New cards
17

What is the therapeutic concentration range for Lidocaine?

1 to 5 mg/L.

New cards
18

What minor CNS effects can be seen with Lidocaine concentrations of 3 to 5 mg/L?

Dizziness, mental confusion, and blurred vision.

New cards
19

At what concentration of Lidocaine have seizures been observed?

Seizures have been seen at concentrations greater than 9 mg/L.

New cards
20

What model is used to describe the volume of distribution (Vd) of Lidocaine following an IV bolus?

A two-compartment model.

New cards
21

When considering Lidocaine's volume of distribution, which compartment should include the myocardium?

The initial volume of distribution (Vi) should include the myocardium.

New cards
22

What body weight measure should be used for calculating the volume of distribution (Vd) of Lidocaine in obese patients?

Total body weight (TBW) should be used for obese patients.

New cards
23

How should the bolus dose (loading dose, LD) of Lidocaine be calculated compared to the total dose of lidocaine?

  • Bolus dose should be calculated using the initial volume of distribution (Vi).

  • Total dose should be calculated using the final volume of distribution (Vd).

New cards
24

What conditions can decrease the volume of distribution (Vd) of Lidocaine?

Congestive heart failure (CHF), severe trauma, and critically ill (ventilated) patients in the ICU.

New cards
25

What condition can increase the volume of distribution (Vd) of Lidocaine?

Chronic liver disease.

New cards
26

What is notable about Lidocaine's first-pass effect?

Lidocaine has a high first-pass effect.

New cards
27

What percentage of Lidocaine is cleared renally, and is there a need for dose adjustment in renal disease?

Less than 5% of Lidocaine is cleared renally, and no dose adjustment is necessary for renal disease

New cards
28

What is the bioavailability (F) of Lidocaine?

The bioavailability (F) of Lidocaine is 0.4, though it is usually variable.

New cards
29

What is the usual clearance rate of Lidocaine?

The usual clearance rate of Lidocaine is 10 mL/kg/min.

New cards
30

What is the clearance rate of Lidocaine in patients with congestive heart failure (CHF) or cirrhosis?

6 mL/kg/min

New cards
31

When is the appropriate time to sample Lidocaine levels after beginning therapy?

4 to 8 hours after beginning therapy.

New cards
32

What factors can alter the pharmacokinetics (PK) of Lidocaine?

Hint: Not renal dysfunction

Heart failure, liver dysfunction, severe trauma, critical illness, and concurrent medications.

New cards

Explore top notes

note Note
studied byStudied by 19 people
... ago
5.0(1)
note Note
studied byStudied by 35 people
... ago
5.0(2)
note Note
studied byStudied by 51 people
... ago
5.0(1)
note Note
studied byStudied by 27 people
... ago
5.0(2)
note Note
studied byStudied by 11 people
... ago
5.0(1)
note Note
studied byStudied by 18 people
... ago
5.0(1)
note Note
studied byStudied by 23343 people
... ago
4.8(116)

Explore top flashcards

flashcards Flashcard (55)
studied byStudied by 7 people
... ago
5.0(1)
flashcards Flashcard (177)
studied byStudied by 271 people
... ago
5.0(2)
flashcards Flashcard (50)
studied byStudied by 17 people
... ago
5.0(1)
flashcards Flashcard (78)
studied byStudied by 279 people
... ago
5.0(2)
flashcards Flashcard (66)
studied byStudied by 17 people
... ago
4.0(1)
flashcards Flashcard (31)
studied byStudied by 7 people
... ago
5.0(2)
flashcards Flashcard (21)
studied byStudied by 10 people
... ago
5.0(2)
flashcards Flashcard (225)
studied byStudied by 98 people
... ago
5.0(3)
robot